nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—Gastrointestinal tract irritation—Capecitabine—colon cancer	0.0554	0.0554	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.0481	0.0481	CcSEcCtD
Acetohydroxamic Acid—Deep vein thrombosis—Capecitabine—colon cancer	0.0325	0.0325	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Irinotecan—colon cancer	0.0248	0.0248	CcSEcCtD
Acetohydroxamic Acid—Deep vein thrombosis—Methotrexate—colon cancer	0.0242	0.0242	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Fluorouracil—colon cancer	0.0237	0.0237	CcSEcCtD
Acetohydroxamic Acid—Injury—Irinotecan—colon cancer	0.0233	0.0233	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Irinotecan—colon cancer	0.0225	0.0225	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Fluorouracil—colon cancer	0.021	0.021	CcSEcCtD
Acetohydroxamic Acid—Depression—Vincristine—colon cancer	0.0169	0.0169	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Capecitabine—colon cancer	0.0166	0.0166	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Irinotecan—colon cancer	0.0163	0.0163	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Capecitabine—colon cancer	0.0159	0.0159	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Capecitabine—colon cancer	0.0151	0.0151	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Capecitabine—colon cancer	0.0147	0.0147	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Vincristine—colon cancer	0.0135	0.0135	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Irinotecan—colon cancer	0.0131	0.0131	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Fluorouracil—colon cancer	0.0126	0.0126	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—colon cancer	0.0123	0.0123	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Vincristine—colon cancer	0.0123	0.0123	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Irinotecan—colon cancer	0.012	0.012	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Irinotecan—colon cancer	0.0119	0.0119	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Acetohydroxamic Acid—Malaise—Irinotecan—colon cancer	0.0117	0.0117	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Fluorouracil—colon cancer	0.0114	0.0114	CcSEcCtD
Acetohydroxamic Acid—Depression—Capecitabine—colon cancer	0.011	0.011	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Methotrexate—colon cancer	0.0109	0.0109	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Irinotecan—colon cancer	0.0109	0.0109	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Fluorouracil—colon cancer	0.0104	0.0104	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Vincristine—colon cancer	0.0103	0.0103	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Irinotecan—colon cancer	0.0101	0.0101	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Fluorouracil—colon cancer	0.00963	0.00963	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vincristine—colon cancer	0.00941	0.00941	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vincristine—colon cancer	0.00935	0.00935	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vincristine—colon cancer	0.00933	0.00933	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Irinotecan—colon cancer	0.00917	0.00917	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.0091	0.0091	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Irinotecan—colon cancer	0.00909	0.00909	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—colon cancer	0.00886	0.00886	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Fluorouracil—colon cancer	0.00878	0.00878	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Capecitabine—colon cancer	0.00878	0.00878	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00872	0.00872	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Irinotecan—colon cancer	0.00869	0.00869	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Fluorouracil—colon cancer	0.00832	0.00832	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—colon cancer	0.00821	0.00821	CcSEcCtD
Acetohydroxamic Acid—Tremor—Capecitabine—colon cancer	0.0081	0.0081	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—colon cancer	0.0081	0.0081	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Capecitabine—colon cancer	0.00802	0.00802	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Capecitabine—colon cancer	0.00799	0.00799	CcSEcCtD
Acetohydroxamic Acid—Malaise—Capecitabine—colon cancer	0.0078	0.0078	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vincristine—colon cancer	0.00777	0.00777	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Capecitabine—colon cancer	0.00764	0.00764	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Irinotecan—colon cancer	0.00756	0.00756	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Capecitabine—colon cancer	0.00734	0.00734	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Capecitabine—colon cancer	0.00727	0.00727	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vincristine—colon cancer	0.00688	0.00688	CcSEcCtD
Acetohydroxamic Acid—Rash—Vincristine—colon cancer	0.00683	0.00683	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vincristine—colon cancer	0.00682	0.00682	CcSEcCtD
Acetohydroxamic Acid—Headache—Vincristine—colon cancer	0.00678	0.00678	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Capecitabine—colon cancer	0.00673	0.00673	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Irinotecan—colon cancer	0.0067	0.0067	CcSEcCtD
Acetohydroxamic Acid—Rash—Irinotecan—colon cancer	0.00665	0.00665	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Irinotecan—colon cancer	0.00664	0.00664	CcSEcCtD
Acetohydroxamic Acid—Headache—Irinotecan—colon cancer	0.00661	0.00661	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—colon cancer	0.00653	0.00653	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vincristine—colon cancer	0.00643	0.00643	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Fluorouracil—colon cancer	0.00642	0.00642	CcSEcCtD
Acetohydroxamic Acid—Rash—Fluorouracil—colon cancer	0.00637	0.00637	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Fluorouracil—colon cancer	0.00636	0.00636	CcSEcCtD
Acetohydroxamic Acid—Headache—Fluorouracil—colon cancer	0.00633	0.00633	CcSEcCtD
Acetohydroxamic Acid—Nausea—Irinotecan—colon cancer	0.00626	0.00626	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Capecitabine—colon cancer	0.00613	0.00613	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.00609	0.00609	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Capecitabine—colon cancer	0.00608	0.00608	CcSEcCtD
Acetohydroxamic Acid—Nausea—Fluorouracil—colon cancer	0.006	0.006	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—colon cancer	0.00597	0.00597	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—colon cancer	0.00595	0.00595	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Capecitabine—colon cancer	0.00582	0.00582	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—colon cancer	0.0058	0.0058	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—colon cancer	0.00541	0.00541	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Capecitabine—colon cancer	0.00506	0.00506	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—colon cancer	0.00501	0.00501	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—colon cancer	0.00457	0.00457	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.00454	0.00454	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—colon cancer	0.00453	0.00453	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Capecitabine—colon cancer	0.00449	0.00449	CcSEcCtD
Acetohydroxamic Acid—Rash—Capecitabine—colon cancer	0.00445	0.00445	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Capecitabine—colon cancer	0.00445	0.00445	CcSEcCtD
Acetohydroxamic Acid—Headache—Capecitabine—colon cancer	0.00442	0.00442	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—colon cancer	0.00433	0.00433	CcSEcCtD
Acetohydroxamic Acid—Nausea—Capecitabine—colon cancer	0.00419	0.00419	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—colon cancer	0.00377	0.00377	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—colon cancer	0.00334	0.00334	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—colon cancer	0.00331	0.00331	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—colon cancer	0.00331	0.00331	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—colon cancer	0.00329	0.00329	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—colon cancer	0.00312	0.00312	CcSEcCtD
